Vaccination with a DNA and MVA 'prime-boost' regimen induces strong CD8 T-cell responses against the immunodominant minor histocompatibility antigen, HA-1: Results of a first-in-man phase I clinical trial

Authors
Category Primary study
JournalBlood
Year 2017
This article has no abstract
Epistemonikos ID: 68f80e46d0d3695b4a7a08bd86c5057ac7367e58
First added on: Feb 08, 2025